BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 34750199)

  • 21. Sentinel lymph node sampling versus full lymphadenectomy in endometrial cancer: a SEER database analysis.
    Nahshon C; Kadan Y; Lavie O; Ostrovsky L; Segev Y
    Int J Gynecol Cancer; 2023 Oct; 33(10):1557-1563. PubMed ID: 37487660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of oncological outcomes between sentinel lymph node biopsy and complete lymphadenectomy for endometrial cancer.
    Makroum AA; Lee YJ; Lee JY; Nam EJ; Kim S; Kim SW; Kim YT
    J Obstet Gynaecol Res; 2023 Aug; 49(8):2118-2125. PubMed ID: 37286510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sentinel Lymph Node Mapping vs Systematic Lymphadenectomy for Endometrial Cancer: Surgical Morbidity and Lymphatic Complications.
    Accorsi GS; Paiva LL; Schmidt R; Vieira M; Reis R; Andrade C
    J Minim Invasive Gynecol; 2020; 27(4):938-945.e2. PubMed ID: 31421249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced lymphedema after sentinel lymph node biopsy versus lymphadenectomy for endometrial cancer.
    Glaser G; Dinoi G; Multinu F; Yost K; Al Hilli M; Larish A; Kumar A; McGree M; Weaver AL; Cheville A; Dowdy S; Mariani A
    Int J Gynecol Cancer; 2021 Jan; 31(1):85-91. PubMed ID: 33243776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization and outcomes of sentinel lymph node biopsy in patients with early stage vulvar cancer.
    Hermann CE; Nasioudis D; Mastroyannis SA; Latif NA; Haggerty AF; Giuntoli Ii RL; Cory L; Kim SH; Morgan MA; Ko EM
    Int J Gynecol Cancer; 2021 Jan; 31(1):40-44. PubMed ID: 33243778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncological safety and perioperative morbidity in low-risk endometrial cancer with sentinel lymph-node dissection.
    Imboden S; Mereu L; Siegenthaler F; Pellegrini A; Papadia A; Tateo S; Mueller MD
    Eur J Surg Oncol; 2019 Sep; 45(9):1638-1643. PubMed ID: 31229377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of sentinel lymph node mapping for patients with FIGO stage I endometrioid endometrial carcinoma.
    Nasioudis D; Byrne M; Ko EM; Giuntoli RL; Haggerty AF; Cory L; Kim SH; Morgan MA; Latif NA
    Gynecol Oncol; 2021 Jun; 161(3):705-709. PubMed ID: 33771397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.
    Tanner EJ; Ojalvo L; Stone RL; Levinson K; Temkin SM; Murdock T; Vang R; Sinno AK; Fader AN
    Int J Gynecol Cancer; 2017 Sep; 27(7):1416-1421. PubMed ID: 30814241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilization and Outcomes of Sentinel Lymph Node Biopsy for Early Endometrial Cancer.
    Matsuo K; Klar M; Nusbaum DJ; Hasanov MF; Vallejo A; Ciesielski KM; Muderspach LI; Roman LD; Wright JD
    Obstet Gynecol; 2022 May; 139(5):809-820. PubMed ID: 35576340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel lymph node biopsy in endometrial cancer-Feasibility, safety and lymphatic complications.
    Geppert B; Lönnerfors C; Bollino M; Persson J
    Gynecol Oncol; 2018 Mar; 148(3):491-498. PubMed ID: 29273307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Perioperative Outcomes between Minimally Invasive Sentinel Node Biopsy and Full Lymphadenectomy for Endometrial Cancer.
    Tait DL; Lehman A; Brown J; Crane EK; Kemp EV; Taylor VD; Naumann RW
    J Minim Invasive Gynecol; 2021 Aug; 28(8):1514-1518. PubMed ID: 33352316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
    Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
    Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of lymphadenectomy in endometrial cancer with nonbulky lymph node metastasis: Comparison of comprehensive surgical staging and sentinel lymph node algorithm.
    Multinu F; Ducie JA; Eriksson AGZ; Schlappe BA; Cliby WA; Glaser GE; Grassi T; Keeney GL; Weaver AL; Abu-Rustum NR; Leitao MM; Mariani A
    Gynecol Oncol; 2019 Nov; 155(2):177-185. PubMed ID: 31604668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer - ENDO-3: ANZGOG trial 1911/2020.
    Obermair A; Nicklin J; Gebski V; Hayes SC; Graves N; Mileshkin L; Lin MY; Beale P; Baxter E; Robledo K; Salomon C; Hanna GB; Janda M
    Int J Gynecol Cancer; 2021 Dec; 31(12):1595-1601. PubMed ID: 34728527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined pelvic and para-aortic is superior to only pelvic lymphadenectomy in intermediate and high-risk endometrial cancer: a systematic review and meta-analysis.
    Petousis S; Christidis P; Margioula-Siarkou C; Papanikolaou A; Dinas K; Mavromatidis G; Guyon F; Rodolakis A; Vergote I; Kalogiannidis I
    Arch Gynecol Obstet; 2020 Jul; 302(1):249-263. PubMed ID: 32468162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does lymphadenectomy improve survival in patients with intermediate risk endometrial cancer? A multicentric study from the FRANCOGYN Research Group.
    Bougherara L; Azaïs H; Béhal H; Canlorbe G; Ballester M; Bendifallah S; Coutant C; Lavoue V; Ouldamer L; Graesslin O; Touboul C; Estevez JP; Collinet P
    Int J Gynecol Cancer; 2019 Feb; 29(2):282-289. PubMed ID: 30718310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel preoperative predictive score to evaluate lymphovascular space involvement in endometrial cancer: an aid to the sentinel lymph node algorithm.
    Capozzi VA; Sozzi G; Uccella S; Ceni V; Cianciolo A; Gambino G; Armano G; Pugliese M; Scambia G; Chiantera V; Berretta R
    Int J Gynecol Cancer; 2020 Jun; 30(6):806-812. PubMed ID: 32284322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers.
    Venigalla S; Chowdhry AK; Shalowitz DI
    Gynecol Oncol; 2018 Jun; 149(3):531-538. PubMed ID: 29559170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intra-operative assessment of sentinel lymph node status by one-step nucleic acid amplification assay (OSNA) in early endometrial cancer: a prospective study.
    Monterossi G; Buca D; Dinoi G; La Fera E; Zannoni GF; Spadola S; Scambia G; Fanfani F
    Int J Gynecol Cancer; 2019 Jul; 29(6):1016-1020. PubMed ID: 31175137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective multicenter international single-arm observational study on the oncological safety of the sentinel lymph node algorithm in stage I intermediate-risk endometrial cancer (SELECT, SEntinel Lymph node Endometrial Cancer Trial).
    Grassi T; Mariani A; Cibula D; Soliman PT; Suman VJ; Weaver AL; Pedra Nobre S; Weigelt B; Glaser GE; Cappuccio S; Abu-Rustum NR
    Int J Gynecol Cancer; 2020 Oct; 30(10):1627-1632. PubMed ID: 32699021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.